Document is current
Any future updates will be listed below
-
Authors
Li, Ye
Deng, Jingjing
Chen, Wenming
-
Funding
Funding for this research was provided by:
the establishment and application of a detection method for minimal residual disease in multiple myeloma based on second-generation sequencing technology (YGLX202309)
- License Information
-
More Information
Article History
Received: 28 October 2024
Accepted: 20 December 2024
First Online: 4 January 2025
Declarations
:
: This study has been approved by the Medical Ethics Committee of Beijing Chaoyang Hospital. We followed the patients through the electronic medical record system without disturbing the patients in any way or interfering with the treatment of the patients. No informed consent was required because the data are anonymized.
: The authors declare no competing interests.
Free to read: This content has been made available to all.
